Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol

AIDS Research and Human Retroviruses

Volumn 15, Issue 4, 1999, Pages 345-353

  Rossi, Luigia ^a   Brandi, Giorgio ^a   Schiavano, Giuditta F ^a   Scarfi, Sonia ^b   Millo, Enrico ^b   Damonte, Gianluca ^b   Benatti, Umberto ^b   De Flora, Antonio ^b   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ETHAMBUTOL; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BIOREACTOR; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRIORITY JOURNAL;

ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; BIOREACTORS; CELLS, CULTURED; DIMERIZATION; ERYTHROCYTES; ETHAMBUTOL; HUMANS; MOLECULAR STRUCTURE; MYCOBACTERIUM AVIUM; ZIDOVUDINE;

EID: 0033004359     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311312     Document Type: Article

References (34)

1. Benson DA and Ellner JJ: Mycobacterium avium complex infection and AIDS: Advances in theory and practice. Clin Infect Dis 1993;17:7-20.
2. Inderlied CB, Kemper CA, and Bermudez LEM: The Mycobacterium avium complex. Clin Microbiol Rev 1993;6:266-310.
3. Low N, Pfluger D, and Egger M: Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: Increasing incidence, unchanged prognosis. AIDS 1997;11:1165-1171.
4. Young LS: Mycobacterium avium complex infection. J Infect Dis 1988;157:863-867.
5. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, and Wynne BA: Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992;165:1082-1085.
6. Ellner JJ, Goldberger MJ, and Parenti DM: Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution. J Infect Dis 1991;163:1326-1335.
7. Horsburg CR: Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324: 1332-1334.
8. Chin DP, Reingold AL, Stone EN, Vittinghoff E, Horsburg CR Jr, Simon EM, Yajko DM, Hadley WK, Ostroff SM, and Hopewell PC: The impact of Mycobacterium avium complex bacteremia and its treatment on survival AIDS patients: A prospective study. J Infect Dis 1994;170:578-584.
9. Horsburg CR, Havlik JA, Ellis DA, Kennedy E, Fann SA, Dubois RE, and Thompson SE: Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991;144:557-559.
10. Masur H: Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med 1993;329:898-904.
11. Havlir DV, Haubrich R, Hwang J, Dunne MW, Currier J, Forthal D, Torriani F, Richman DD, and Allen J: Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: A case control study. J Infect Dis 1998; 177:595-599.
12. Bermudez LE, Inderlied CB, and Young LS: Mycobacterium avium complex in AIDS. Curr Clin Top Infect Dis 1992;12:257-281.
13. Gordon SM Jr, Horsburg CR, Peloquin CA, et al.: Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Infect Dis 1993;168: 1559-1562.
14. DeLoach JR and Sprandel U. Red Blood Cells as Carriers for Drugs. S. Karger, Basel, 1985.
15. De Flora A, Benatti U, Guida L, and Zocchi E: Encapsulation of Adriamycin in human erythrocytes. Proc Natl Acad Sci USA 1986;83:7029-7033.
16. Magnani M and DeLoach JR: The Use of Resealed Erythrocytes as Carriers and Bioreactors. Plenum Press, New York, 1991.
17. Benatti U, Giovine M, Damonte G, Gasparini A, Scarfi F, De Flora A, Fraternale A, Rossi L, and Magnani M: Azidothymidine homodinucleotide-loaded erythrocytes as bioreactors for slow delivery of the antiretroviral drug azidothymidine. Biochem Biophys Res Commun 1996;220:20-25.
18. Rossi L, Brandi G, Schiavano GF, Balestra E, Millo E, Scarfi S, Damonte G, Gasparini A, Magnani M, Perno CF, Benatti U, and De Flora A: Macrophage protection against human immunodeficiency virus or herpes simplex virus by red cell-mediated delivery of a heterodinucleotide of azidothimidine and acyclovir. Aids Res Hum Retroviruses 1998;14:435-444.
19. De Flora A, Zocchi E, Guida L, Polvani C, and Benatti U: Conversion of encapsulated 5-fluoro-2′-deoxyuridine-5′-monophosphate to the antineoplastic drug 5-fluoro-2′-deoxyuridine in human erythrocytes. Proc Natl Acad Sci USA 1988;85:3145-3149.
20. Magnani M, Bianchi M, Rossi L, and Stocchi V: Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity. Biochem Biophys Res Commun 1985;164:446-452.
21. Hostetler KY, Stuhmiller LM, Lenting BM, van den Bosch H, and Richman DD: Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides. J Biol Chem 1990;265:6112-6117.
22. Cherbuliez E and Rabinovitz J: Recherches fur sur la formation et la transformation des esters. Helv Chim Acta 1956;39:1455-1461.
23. van Wijk GMT, Hostetler KY, and van den Bosch H: Antiviral nucleoside diphosphate diglycerides: Improved synthesis and facilitated purification. J Lipid Res 1992;33:1211-1219.
24. Magnani M, Rossi L, Bianchi M, Cucchiarini L, and Stocchi V: Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples. J Chromatogr BA 1989;491:215-220.
25. Magnani M, Rossi L, Brandi G, Schiavano GF, Montroni M, and Piedimonte G: Targeting antiretroviral nucleoside analogues in phosphorilated form to macrophages: In vitro and in vivo studies. Proc Natl Acad Sci USA 1992;89:6477-6481.
26. Inderlied CB, Burnham LB, Wu M, Young LS, and Bermudez LEM: Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages. Antimicrob Agents Chemother 1994;38:1838-1843.
27. Magnani M, Giovine M, Fraternale A, Damonte G, Rossi L, Scarfi S, Benatti U, and De Flora A: Red blood cells as a delivery system for AZT. Drug Delivery 1995;2:57-61.
28. Rastogi N, Labrousse V, and Bryskier A: Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages. Antimicrob Agents Chemother 1995;39:976-978.
29. Kemper CA, Havlir D, Haghighat D, Dubé M, Bartok AE, Sison JP, et al.: The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis 1994;170:157-164.
30. Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, et al.: A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996;335: 377-383.
31. Crowle AJ, Tsang AY, Vatter AE, and May MH: Comparison of laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol 1986;24:812-821.
32. Furman PA, Fyfe JA, StClair M, Weinhold K, Rideout JL, Freeman GA, Nusinoff-Lehrman S, Bolognesi DP, Broder S, Mitsuya H, and Barry DW: Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 1986;83:8333-8337.
33. Robbins BL, Rodman J, McDonald C, Srinivas RV, Flynn PM, and Fridland A: Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Antimicrob Agents Chemother 1994;38:115-121.
34. Magnani M, Rossi L, D'Ascenzo M, Panzani I, Bigi L, and Zanella A: Erythrocyte engineering for drug delivery and targeting. Biotechnol Appl Biochem 1998;28:1-6.